Rezultati - Jo‐Anne Vergilio
- Showing 1 - 20 results of 30
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia od Vijay G. Sankaran, Roxanne Ghazvinian, Ron Do, Prathapan Thiru, Jo‐Anne Vergilio, Alan H. Beggs, Colin A. Sieff, Stuart H. Orkin, David G. Nathan, Eric S. Lander, Hanna T. Gazda
Izdano 2012Artigo -
8
Utility of FDG-PET scanning in lymphoma by WHO classification od Rebecca Elstrom, Liang Guan, Gary Baker, Khozaim Nakhoda, Jo‐Anne Vergilio, Hongming Zhuang, Stephanie Pitsilos, Adam Bagg, Lisa Downs, Amit K. Mehrotra, Scott Y. H. Kim, Abass Alavi, Stephen J. Schuster
Izdano 2003Artigo -
9
SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association od Douglas I. Lin, Justin Allen, Jonathan L. Hecht, Jonathan Keith Killian, Nhu Ngo, Claire Edgerly, Eric A. Severson, Siraj M. Ali, Rachel Erlich, Shakti Ramkissoon, Jo‐Anne Vergilio, Jeffrey S. Ross, Julia A. Elvin
Izdano 2019Artigo -
10
Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May... od James Suh, Adrienne Johnson, Lee A. Albacker, Kai Wang, Juliann Chmielecki, Garrett M. Frampton, Laurie M. Gay, Julia A. Elvin, Jo‐Anne Vergilio, Siraj M. Ali, Vincent A. Miller, Philip J. Stephens, Jeffrey S. Ross
Izdano 2016Artigo -
11
Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials od Natalie Galanina, Rafael Bejar, Michael Y. Choi, Aaron M. Goodman, Matthew J. Wieduwilt, Carolyn Mulroney, Lisa Kim, Huwate Yeerna, Pablo Tamayo, Jo‐Anne Vergilio, Tariq I. Mughal, Vincent A. Miller, Catriona Jamieson, Razelle Kurzrock
Izdano 2018Artigo -
12
Nonamplification <i>ERBB2</i> genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti‐HER2 targeted therapies od Jeffrey S. Ross, Laurie M. Gay, Kai Wang, Siraj M. Ali, Saranya Chumsri, Julia A. Elvin, Ron Bose, Jo‐Anne Vergilio, James Suh, Roman Yelensky, Doron Lipson, Juliann Chmielecki, Stanley E. Waintraub, Brian Leyland‐Jones, Vincent A. Miller, Philip J. Stephens
Izdano 2016Artigo -
13
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in <i>ERBB2</i> and <i>ERBB3</i> od Jeffrey S. Ross, Marwan Fakih, Siraj M. Ali, Julia A. Elvin, Alexa B. Schrock, James Suh, Jo‐Anne Vergilio, Shakti Ramkissoon, Eric A. Severson, Sugganth Daniel, David Fabrizio, Garrett M. Frampton, James Sun, Vincent A. Miller, Philip J. Stephens, Laurie M. Gay
Izdano 2018Artigo -
14
The distribution of <i> <scp>BRAF</scp> </i> gene fusions in solid tumors and response to targeted therapy od Jeffrey S. Ross, Kai Wang, Juliann Chmielecki, Laurie M. Gay, Adrienne Johnson, Jacob Chudnovsky, Roman Yelensky, Doron Lipson, Siraj M. Ali, Julia A. Elvin, Jo‐Anne Vergilio, Steven Roels, Vincent A. Miller, Brooke N. Nakamura, Adam Gray, Michael K.K. Wong, Philip J. Stephens
Izdano 2015Artigo -
15
Recurrent BRAF mutations in Langerhans cell histiocytosis od Gayane Badalian‐Very, Jo‐Anne Vergilio, Barbara Degar, Laura E. MacConaill, Barbara Brandner, Monica L. Calicchio, Frank C. Kuo, Azra H. Ligon, Kristen E. Stevenson, Sarah M. Kehoe, Levi A. Garraway, William C. Hahn, Matthew Meyerson, Mark D. Fleming, Barrett J. Rollins
Izdano 2010Artigo -
16
Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options od Laurie M. Gay, Sungeun Kim, Kyle Fedorchak, Madappa N. Kundranda, Yazmín Odia, Chaitali Nangia, James Battiste, Gerardo Colón‐Otero, Steven Powell, Jeffery S. Russell, Julia A. Elvin, Jo-Anne Vergilio, James Suh, Siraj M. Ali, Philip J. Stephens, Vincent A. Miller, Jeffrey S. Ross
Izdano 2017Artigo -
17
Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies od Jeffrey S. Ross, Laurie M. Gay, K. Wang, Jo‐Anne Vergilio, James Suh, Shakti Ramkissoon, Hilary Somerset, Jennifer M. Johnson, Jeffery S. Russell, Siraj M. Ali, Alexa B. Schrock, David Fabrizio, Garrett M. Frampton, V.A. Miller, Philip J. Stephens, Julia A. Elvin, Daniel W. Bowles
Izdano 2017Artigo -
18
Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens od Eric A. Severson, Gregory Riedlinger, Caitlin Connelly, Jo-Anne Vergilio, Mendel Goldfinger, Shakti Ramkissoon, Garrett M. Frampton, Jeffrey S. Ross, Anthony Fratella-Calabrese, Laurie M. Gay, Siraj Ali, Vincent A. Miller, Julia A. Elvin, Mohammad Hadigol, Kim M. Hirshfield, Lorna Rodríguez-Rodríguez, Shridar Ganesan, Hossein Khiabanian
Izdano 2018Carta -
19
Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors od Andrea Necchi, Gennady Bratslavsky, Oleg Shapiro, Julia A. Elvin, Jo‐Anne Vergilio, Jonathan Keith Killian, Nhu Ngo, Shakti Ramkissoon, Eric A. Severson, Amanda Hemmerich, Siraj M. Ali, Jon Chung, Prasanth Reddy, Vincent A. Miller, Alexa B. Schrock, Laurie M. Gay, Jeffrey S. Ross, Joseph M Jacob
Izdano 2019Artigo -
20
Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies od Rami N. Al‐Rohil, Ashley J. Tarasen, J. Andrew Carlson, Kai Wang, Adrienne Johnson, Roman Yelensky, Doron Lipson, Julia A. Elvin, Jo‐Anne Vergilio, Siraj M. Ali, James Suh, Vincent A. Miller, Philip J. Stephens, Prasanth Ganesan, Filip Janků, Daniel D. Karp, Vivek Subbiah, Martín C. Mihm, Jeffrey S. Ross
Izdano 2015Artigo
Iskalna orodja:
Sorodne teme
Medicine
Biology
Internal medicine
Cancer research
Genetics
Cancer
Gene
Pathology
Oncology
Biochemistry
Chromosome
Colorectal cancer
Immunology
KRAS
Mutation
Adenocarcinoma
Bone marrow
Computational biology
Bioinformatics
CDKN2A
Clinical trial
Computer science
Disease
HRAS
Histiocytosis
Immunohistochemistry
Langerhans cell histiocytosis
Myeloid
Myeloid leukemia
Operating system